MeSH tree: L01.462.750.245.667
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells ...
Aug 10, 2026
0
47
A new open resource of cancer models has enabled researchers to create the first large-scale map of the genes that cancers rely on to survive, offering new avenues for research into better and less toxic treatments for patients.
Aug 5, 2026
0
5
Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder that impairs lung function, predisposes people to persistent airway infections and puts them at risk of ...
Aug 3, 2026
0
4
Variants of sexually transmitted Shigella—a bacterial infection that causes bloody or prolonged diarrhea and can lead to severe dehydration—are causing more disease and becoming increasingly antibiotic-resistant among sections ...
Jul 9, 2026
0
156
A new study, co-led by Mathias Schmidt from the Max Planck Institute of Psychiatry in Munich and Juan Pablo Lopez from Karolinska Institutet in Sweden, focused on the FKBP5 gene and its encoded protein, FKBP51, a well-established ...
Jul 7, 2026
0
2
New research to be presented today at the annual conference of the European Society of Human Genetics shows that a cancer patient's genetic ancestry can have a significant effect both on how their disease progresses and their ...
Jun 14, 2026
0
28
Patients with COVID-19 can show several different antiviral immune response patterns, which may influence how the disease develops. This is shown in a new study from Karolinska Institutet, published in Genome Medicine, highlighting ...
Jun 12, 2026
0
8
To better understand what drives the emergence of symptoms in Rett syndrome, researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital took a closer ...
Jun 10, 2026
0
5
For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently ...
Jun 9, 2026
0
10
UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly one in 2,000 boys.
May 18, 2026
0
7
